It is therefore potentially highly significant that patients whose tumor tissue was in the lowest quartile of nuclear SBP1 expression were significantly more likely to recur, as indicated by rising levels of prostate specific antigen (PSA), than patients with higher nuclear SBP1 [62]. The gene discussed is KLK3; the disease is neoplasm.